A Better Experimental Method to Detect the Sensitivity of Cancer Cells to Anticancer Drugs After Adenovirus-Mediated Introduction of Two Kinds of P53 in Vivo
Anti-Cancer Drugs - United States
doi 10.1097/cad.0000000000000259
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2015
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)